Technical Analysis for LIFE - aTyr Pharma, Inc.

Grade Last Price % Change Price Change
F 3.7 -7.04% -0.28
LIFE closed down 7.04 percent on Thursday, April 15, 2021, on 26 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical LIFE trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup -7.04%
Wide Bands Range Expansion -7.04%
Oversold Stochastic Weakness -7.04%
Wide Bands Range Expansion -1.07%
Gapped Down Weakness -1.07%
Oversold Stochastic Weakness -1.07%
Fell Below 200 DMA Bearish -7.73%
Older End-of-Day Signals for LIFE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% 1 day ago
Down 3% 1 day ago
Down 2 % 1 day ago
Down 1% 1 day ago
Rose Above Previous Day's High 2 days ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

aTyr Pharma, Inc. engages in the discovery and clinical development of protein based therapeutics for patients suffering from severe and rare diseases. The company is developing Resolaris, which is in Phase Ib/II clinical trials in adult patients with facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component. Its products pipeline also includes Resolaris for treatment of patients with early onset facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component and limb-girdle muscular dystrophies, as well as rare pulmonary diseases with an immune component. In addition, the company is developing iMod.Fc, a preclinical immuno-modulatory domain program. The company was founded in 2005 and is headquartered in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Development Organ Systems Rare Diseases Dystrophy Pulmonary Disease Muscular Dystrophy Myopathy Facioscapulohumeral Muscular Dystrophy Muscular Dystrophies Severe And Rare Diseases Limb Girdle Muscular Dystrophies Muscular Dystrophy Community Assistance Research And Education Amendments Musculoskeletal System

Is LIFE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.33
52 Week Low 2.93
Average Volume 1,725,045
200-Day Moving Average 4.15
50-Day Moving Average 4.93
20-Day Moving Average 4.51
10-Day Moving Average 4.19
Average True Range 0.45
ADX 10.97
+DI 16.79
-DI 20.34
Chandelier Exit (Long, 3 ATRs ) 4.95
Chandelier Exit (Short, 3 ATRs ) 5.06
Upper Bollinger Band 5.49
Lower Bollinger Band 3.54
Percent B (%b) 0.08
BandWidth 43.13
MACD Line -0.26
MACD Signal Line -0.18
MACD Histogram -0.0843
Fundamentals Value
Market Cap 37.69 Million
Num Shares 10.2 Million
EPS -10.21
Price-to-Earnings (P/E) Ratio -0.36
Price-to-Sales 3.96
Price-to-Book 1.44
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.10
Resistance 3 (R3) 4.15 4.06 4.04
Resistance 2 (R2) 4.06 3.96 4.04 4.01
Resistance 1 (R1) 3.88 3.89 3.83 3.83 3.99
Pivot Point 3.79 3.79 3.77 3.77 3.79
Support 1 (S1) 3.61 3.69 3.57 3.57 3.41
Support 2 (S2) 3.52 3.62 3.50 3.39
Support 3 (S3) 3.34 3.52 3.36
Support 4 (S4) 3.30